Insider · CIK 0001304340

PANOFF MARC L

Reports to the SEC for 4 companies · FORT LEE, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001304340

Forms 4 and 5

Insider transactions

19 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-09-10	LBRXLB PHARMACEUTICALS INC · Employee Stock Option (Right to Buy)D Disposition to Issuer	Senior Vice President, Finance	DDisposition to Issuer	−3,944 sh	—	—	0
2025-09-10	LBRXLB PHARMACEUTICALS INC · Employee Stock Option (Right to Buy)A Award	Senior Vice President, Finance	AAward	+3,944 sh	—	—	3,944
2025-09-10	LBRXLB PHARMACEUTICALS INC · Employee Stock Option (Right to Buy)D Disposition to Issuer	Senior Vice President, Finance	DDisposition to Issuer	−896 sh	—	—	0
2025-09-10	LBRXLB PHARMACEUTICALS INC · Employee Stock Option (Right to Buy)A Award	Senior Vice President, Finance	AAward	+896 sh	—	—	896
2025-09-10	LBRXLB PHARMACEUTICALS INC · Employee Stock Option (Right to Buy)D Disposition to Issuer	Senior Vice President, Finance	DDisposition to Issuer	−1,255 sh	—	—	0
2025-09-10	LBRXLB PHARMACEUTICALS INC · Employee Stock Option (Right to Buy)A Award	Senior Vice President, Finance	AAward	+1,255 sh	—	—	1,255
2025-09-10	LBRXLB PHARMACEUTICALS INC · Employee Stock Option (Right to Buy)D Disposition to Issuer	Senior Vice President, Finance	DDisposition to Issuer	−14.3K sh	—	—	0
2025-09-10	LBRXLB PHARMACEUTICALS INC · Employee Stock Option (Right to Buy)A Award	Senior Vice President, Finance	AAward	+14.3K sh	—	—	14,343
2025-09-10	LBRXLB PHARMACEUTICALS INC · Employee Stock Option (Right to Buy)D Disposition to Issuer	Senior Vice President, Finance	DDisposition to Issuer	−7,171 sh	—	—	0
2025-09-10	LBRXLB PHARMACEUTICALS INC · Employee Stock Option (Right to Buy)A Award	Senior Vice President, Finance	AAward	+7,171 sh	—	—	7,171
2025-09-10	LBRXLB PHARMACEUTICALS INC · Employee Stock Option (Right to Buy)A Award	Senior Vice President, Finance	AAward	+90.5K sh	—	—	90,525
2014-02-24	TVTXTravere Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+100K sh	—	—	221,100
2013-08-15	TVTXTravere Therapeutics, Inc.P Purchase	Chief Financial Officer	PPurchase	+1,100 sh	$4.50	+$4,950	121,100
2013-08-15	TVTXTravere Therapeutics, Inc. · Common Stock Purchase WarrantsP Purchase	Chief Financial Officer	PPurchase	+550 sh	—	—	550
2011-05-10	NEUROLOGIX INC/DEOptions to acquire Common StockA Award	CFO, TREASURER & SECRETARY	AAward	+150K sh	—	—	735,000
2010-05-11	NEUROLOGIX INC/DEOptions to acquire Common StockA Award	CFO, TREASURER & SECRETARY	AAward	+110K sh	—	—	585,000
2009-05-07	NEUROLOGIX INC/DEOptions to acquire Common StockA Award	CFO, TREASURER & SECRETARY	AAward	+110K sh	—	—	475,000
2007-05-09	NEUROLOGIX INC/DEOptions to acquire common stockA Award	CFO, TREASURER & SECRETARY	AAward	+75K sh	—	—	255,000
2004-12-14	NEPHNEPHROS INC · Non-qualified stock option (right to buy)A Award	Chief Financial Officer	AAward	+20K sh	—	—	20,000

Recent filings

Accepted (ET)
Sep 294
PANOFF MARC L0001304340-25-000006
SEC(opens sec.gov)
Feb 284
Retrophin, Inc.0001193805-14-000382
SEC(opens sec.gov)
Aug 204
Retrophin, Inc.0001193805-13-001504
SEC(opens sec.gov)
May 114
PANOFF MARC L0001144204-11-028193
SEC(opens sec.gov)
May 134
PANOFF MARC L0001209191-10-027509
SEC(opens sec.gov)
May 114
PANOFF MARC L0001209191-09-025830
SEC(opens sec.gov)
May 114
NEUROLOGIX INC/DE0001317713-07-000005
SEC(opens sec.gov)
Dec 164
NEPHROS INC0000922423-04-002034
SEC(opens sec.gov)

Companies

Address

C/O NEUROLOGIX, INC. ONE BRIDGE PLAZA

FORT LEE, NJ, 07024